FAQ Animal Models & Model SelectionCell & Gene Therapy / Viral VectorIn Vivo Efficacy & PharmacologyPK / PD / DMPK & BioanalysisPreclinical CRO & OutsourcingPreclinical Strategy & Pilot StudiesProject Planning & Working With ToprionSafety & Exploratory Toxicology How do I choose between Sprague Dawley, Wistar, and Long Evans outbred rats for preclinical pharmacology and safety studies? 2026-08-26 Why are male mice predominantly used in myocardial fibrosis studies, and when should female cohorts be included? 2026-08-26 How does the Cre/LoxP recombination system work in conditional gene editing for preclinical animal models? 2026-08-26 What should I check if there is no target protein band on a Western blot during target or phenotype validation? 2026-08-26 How do I choose between ELISA and multiplex bead assays (CBA) for cytokine release testing? 2026-08-26 How to Choose a Preclinical CRO: 7 Questions for Early Drug Development 2026-09-21 What causes high variability in Western blot results, and how can assay reproducibility be improved across preclinical studies? 2026-08-26 What causes low yield or lost signal during membrane protein extraction and Western blot detection? 2026-08-26 Should I build a cell model or generate an animal model first to validate a novel mutation? 2026-08-26 How do I choose between gene therapy and conventional small-molecule or biologic drugs in preclinical glaucoma drug development? 2026-08-26 Project Planning & Working With Toprion 2026-08-26 Safety & Exploratory Toxicology 2026-08-26 Can the optomotor response (OMR) assay be used to evaluate color vision in preclinical ophthalmic studies? 2026-08-26 How do behavioral test selection and stimulus direction impact the assessment of monocular visual differences in rodent studies? 2026-08-26
How do I choose between Sprague Dawley, Wistar, and Long Evans outbred rats for preclinical pharmacology and safety studies? 2026-08-26
Why are male mice predominantly used in myocardial fibrosis studies, and when should female cohorts be included? 2026-08-26
How does the Cre/LoxP recombination system work in conditional gene editing for preclinical animal models? 2026-08-26
What should I check if there is no target protein band on a Western blot during target or phenotype validation? 2026-08-26
How do I choose between ELISA and multiplex bead assays (CBA) for cytokine release testing? 2026-08-26
What causes high variability in Western blot results, and how can assay reproducibility be improved across preclinical studies? 2026-08-26
What causes low yield or lost signal during membrane protein extraction and Western blot detection? 2026-08-26
Should I build a cell model or generate an animal model first to validate a novel mutation? 2026-08-26
How do I choose between gene therapy and conventional small-molecule or biologic drugs in preclinical glaucoma drug development? 2026-08-26
Can the optomotor response (OMR) assay be used to evaluate color vision in preclinical ophthalmic studies? 2026-08-26
How do behavioral test selection and stimulus direction impact the assessment of monocular visual differences in rodent studies? 2026-08-26
